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Background
Traditionally, KS has been associated with advanced age
or with significant immunosuppression. We recently
reported an atypical cohort of antiretroviral-treated HIV
infected patients who developed cutaneous KS despite
having undetectable plasma HIV RNA levels and high
CD4+ T cell counts. The KS lesions seen in these patients
were indolent and reminiscent of classical KS seen in the
HIV-negative elderly. The mechanism of KS in the elderly
remains undefined, but many have postulated a potential
role of immunosenescence, which is generally defined as
the gradual loss of immunologic function during
advanced age. Given emerging evidence suggesting that
prolonged periods of untreated HIV infection results in
accelerated and perhaps irreversible "aging" of the
immune system, we hypothesized that immunosenes-
cence may account for the development of KS in other-
wise young well-treated HIV infected individuals.
Methods
Peripheral blood was collected from two patient groups:
(1) antiretroviral-treated HIV infected patients with unde-
tectable viral loads who developed KS (n = 10) and (2)
treated patients with undetectable viral loads who did not
develop KS (n = 86). All KS cases had CD4 counts >300.
Flow cytometry was performed on cyropreserved cells to
determine the proportion of CD4+ and CD8+ T cells that
were activated or senescent. CD38 and HLADR were used
to measure activation and CD57 was used as a measure of
immunosencence as this cell surface marker has been
associated with shorter telomere length, a history of cell
division, and decreased proliferative ability.
Results
Consistent with our initial hypothesis, in patients who
had developed KS a higher percentage of CD4+ T cells
expressed CD57 than in those individuals who did not
develop KS (median of 10.8% vs. 6.4%, P = p = 0.03).
Similarly, those with KS had higher percentage of CD8+T
cells that expressed CD57 compared with those without
KS (42% vs. 32%, P = 0.02). There was no difference in T
cell activation markers between the KS and non-KS
groups. The difference in CD57 expression between those
with and without KS was not explained by age, gender or
HCV co-infection.
Conclusion
In this study we find that a well recognized global immu-
nosenescence marker (CD57) was elevated among
patients with well-controlled HIV who developed KS as
compared to comparable patients who do not develop KS.
Collectively, these observations suggest that (1) HIV infec-
tion drives premature immunologic aging, (2) HAART
does not fully reverse this process and (3) HIV associated
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immunosenescence may result in increased risk of the
type of KS commonly observed in certain elderly popula-
tions. This association of immunosenescence and chronic
well-controlled HIV in the setting of an AIDS-defining
malignancy carries implications for adequacy of current
immunologic monitoring of HIV progression. It also
raises questions with regard to regulation of chronic
inflammation and replication in the long-term manage-
ment of HIV infection, and for the potential of immune-
related morbidity in the aging population of HIV-positive
patients.Page 2 of 2
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